Clinical and functional consequences of GRIA variants in patients with neurological diseases
Wenshu XiangWei,Riley E. Perszyk,Nana Liu,Yuchen Xu,Subhrajit Bhattacharya,Gil H. Shaulsky,Constance Smith-Hicks,Ali Fatemi,Andrew E. Fry,Kate Chandler,Tao Wang,Julie Vogt,Julie S. Cohen,Alex R. Paciorkowski,Annapurna Poduri,Yuehua Zhang,Shuang Wang,Yuping Wang,Qiongxiang Zhai,Fang Fang,Jie Leng,Kathryn Garber,Scott J. Myers,Robin-Tobias Jauss,Kristen L. Park,Timothy A. Benke,Johannes R. Lemke,Hongjie Yuan,Yuwu Jiang,Stephen F. Traynelis
DOI: https://doi.org/10.1007/s00018-023-04991-6
IF: 8
2023-11-05
Cellular and Molecular Life Sciences
Abstract:AMPA receptors are members of the glutamate receptor family and mediate a fast component of excitatory synaptic transmission at virtually all central synapses. Thus, their functional characteristics are a critical determinant of brain function. We evaluate intolerance of each GRIA gene to genetic variation using 3DMTR and report here the functional consequences of 52 missense variants in GRIA1–4 identified in patients with various neurological disorders. These variants produce changes in agonist EC 50 , response time course, desensitization, and/or receptor surface expression. We predict that these functional and localization changes will have important consequences for circuit function, and therefore likely contribute to the patients' clinical phenotype. We evaluated the sensitivity of variant receptors to AMPAR-selective modulators including FDA-approved drugs to explore potential targeted therapeutic options.
cell biology,biochemistry & molecular biology